CCM
RVMD icon

Cinctive Capital Management’s Revolution Medicines RVMD Stock Holding History

Cinctive Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.13M Buy
93,857
+51,222
+120% +$5.17M 0.59% 45
2025
Q4 		$3.4M Buy
+42,635
New +$2.8M 0.18% 153
2025
Q2 		– Sell
-11,343
Closed -$401K – 458
2025
Q1 		$401K Sell
11,343
-23,447
-67% -$952K 0.03% 272
2024
Q4 		$1.52M Sell
34,790
-18,571
-35% -$937K 0.08% 248
2024
Q3 		$2.42M Buy
53,361
+30,430
+133% +$1.33M 0.13% 212
2024
Q2 		$890K Sell
22,931
-15,230
-40% -$569K 0.04% 323
2024
Q1 		$1.23M Sell
38,161
-26,947
-41% -$799K 0.06% 268
2023
Q4 		$1.87M Buy
+65,108
New +$1.56M 0.12% 191

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cinctive Capital Management's RVMD Position: Q1 2026 in Review

Cinctive Capital Management increased its Revolution Medicines (RVMD) stake by 120% in Q1 2026, buying an estimated $5.17M and bringing the position to 93,857 shares worth $9.13M. The position accounts for 0.59% of the portfolio, ranked #45.

Cinctive Capital Management first reported a position in RVMD in Q4 2023 and has held it in 8 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Cinctive Capital Management held 93,857 shares of Revolution Medicines worth $9.13M as of Q1 2026.
  • Cinctive Capital Management bought 51,222 Revolution Medicines shares in Q1 2026, an estimated $5.17M.
  • Revolution Medicines made up 0.59% of Cinctive Capital Management's portfolio in Q1 2026, its #45 holding.
  • Cinctive Capital Management first reported a position in Revolution Medicines in Q4 2023 and has held it in 8 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.